Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial

Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial

Abstract Background Mild cognitive impairment (MCI) is considered an intermediate phase between normal aging and dementia. As the majority of cases of amnestic MCI (aMCI) progress to Alzheimer’s disease (AD), it is considered the prodromal stage of AD, and a treatment target for prevention of furthe...

Full description

Bibliographic Details
Main Authors: Hee-Yeon Shin, Ha-Ri Kim, Geon-Ho Jahng, Chul Jin, Seungwon Kwon, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Chang-Nam Ko, Jung-Mi Park
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Mild cognitive impairment
Amnestic mild cognitive impairment
Herbal medicine
Traditional Korean medicine
Kami-guibi-tang
Seoul neuropsychological screening battery
Online Access:https://doi.org/10.1186/s12906-021-03428-6

Internet

https://doi.org/10.1186/s12906-021-03428-6

Similar Items